EuBiologics Co., Ltd.

About:

EuBiologics provides and develops biopharmaceutical products.

Website: http://www.eubiologics.com/en/main/

Top Investors: Korea Investment Partners, IMM Investment, Global Health Investment Fund (GHIF), KNet Investment Partners, Korea Seoul Life Science Fund

Description:

EuBiologics offers customized services for mammalian cell and microbial-derived biopharmaceuticals, from cell line development to GMP production. Their services are provided in cooperation with companies, aiming to help clients easily undertake their projects. They offer Euvichol-Plus, the COVID-19 Diagnostic Kit, EcML, and rCRM. EuBiologics contribute to human health throughout life.

Total Funding Amount:

$7.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2010-03-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2018-10-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai